Related Articles
Tumor organoid model of colorectal cancer (Review)
Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review)
Establishment and characterization of prostate organoids from treatment‑naïve patients with prostate cancer
Sphere‑forming assay vs. organoid culture: Determining long‑term stemness and the chemoresistant capacity of primary colorectal cancer cells
Construction of <em>in vitro</em> patient‑derived tumor models to evaluate anticancer agents and cancer immunotherapy